| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 30.0K | $44.4K | - | |
| CFO | 15.0K | $22.2K | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2017 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,900 | $27.00 | $105,300.00 | -56.6% | |
| Jan 3, 2017 | Herman Alan C. | Chief Scientific Officer | Sell | 11,333 | $27.95 | $316,722.45 | -4.3% | |
| Dec 16, 2016 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,900 | $28.30 | $110,364.93 | -62.7% | |
| Dec 8, 2016 | Wahlstrom Mats58 | Director | Sell | 53,583 | $27.52 | $1,474,677.10 | -53.7% | |
| Dec 1, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 11,333 | $27.40 | $310,523.10 | -3.9% | |
| Nov 18, 2016 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,900 | $28.19 | $109,955.04 | -62.7% | |
| Nov 1, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 11,333 | $27.53 | $312,041.69 | -7.2% | |
| Oct 21, 2016 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,900 | $30.62 | $119,402.79 | -62.7% | |
| Oct 3, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 11,333 | $25.69 | $291,201.29 | -3.4% | |
| Sep 26, 2016 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,900 | $29.88 | $116,549.94 | -62.7% |